NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
04/11/2023
Back to search
Official data from USPTO
APMONIA THERAPEUTICS
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
APMONIA THERAPEUTICS
ST13
US500000097242123Class
1, 42
Filing
97242123
Registration
7022567
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
17
Latest update
04/11/2023
Trademark type
Word
Nice classes
1, 42
Filing date
01/27/2022
Registration date
04/11/2023
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/11/2023
Last transaction
04/11/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
99
Owner location
Reims, FR
Examiner
CARLYLE, SHAUNIA
Law office
M10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
A. T. (pessoa física)
Representatives
PINA CAMPAGNA CARTER, DELUCA AND FARRELL LLP
Technical classification
Nice Classes
Class 1Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals for use in industry and science
Class 42
Scientific research; Technical research in the field of pharmaceutical studies
Publications
History of USPTO decisions and trademark events.
17 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
04/11/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/24/2023
PUBO
PUBLISHED FOR OPPOSITION
01/24/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/04/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
12/16/2022
XAEC
EXAMINER'S AMENDMENT ENTERED
11/30/2022
ALIE
ASSIGNED TO LIE
11/30/2022
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/29/2022
GNEA
EXAMINERS AMENDMENT E-MAILED
11/29/2022
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/29/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/09/2022
GNRT
NON-FINAL ACTION E-MAILED
11/09/2022
CNRT
NON-FINAL ACTION WRITTEN
11/09/2022
DOCK
ASSIGNED TO EXAMINER
11/07/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/01/2022
NWAP
NEW APPLICATION ENTERED
01/31/2022
Continuous trademark protection
Get notified about every new filing that threatens APMONIA THERAPEUTICS or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.